Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT2 | O75908 | 1/20 | 0.47 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 3/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.45 |
| ▸ | CETP | P11597 | 4/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.41 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4878268 | 1.00 | SOAT2 (0.47) | SOAT2SOAT1FAAHEPHX2CETP | |
| SCHEMBL31590883 | 1.00 | SOAT2 (0.47) | SOAT2SOAT1FAAHEPHX2CETP | |
| SCHEMBL31590628 | 0.94 | TSHR (0.46) | SOAT2SOAT1CETPALOX15TSHR | |
| SCHEMBL31590664 | 0.87 | TSHR (0.48) | ALOX15TSHR | |
| SCHEMBL4609010 | 0.84 | SOAT2 (0.46) | SOAT2SOAT1FAAHEPHX2TSHR | |
| SCHEMBL4609004 | 0.84 | SOAT2 (0.46) | SOAT2SOAT1FAAHEPHX2TSHR | |
| SCHEMBL1287657 | 0.80 | TSHR (0.52) | ALOX15TSHR | |
| SCHEMBL21518324 | 0.79 | FAAH (0.44) | SOAT2SOAT1FAAHEPHX2TSHR | |
| SCHEMBL31590296 | 0.79 | EPHX2 (0.49) | SOAT2SOAT1FAAHEPHX2CETP | |
| SCHEMBL4606349 | 0.78 | AOX1 (0.44) | SOAT2SOAT1FAAHEPHX2CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080091040-A1 | Optically active alkenylphosphinic acid ester and process for producing the same | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2008-04-17 | — | — | US | disclosed |
| EP-1375505-B1 | OPTICALLY ACTIVE ALKENYLPHOSPHINIC ACID ESTER AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE & TECH AGENCY (JP) | 2006-09-13 | — | — | EP | disclosed |
| US-20040092752-A1 | Optically active alkenylphosphinic acid esters and process for producing the same | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1375505-A1 | OPTICALLY ACTIVE ALKENYLPHOSPHINIC ACID ESTER AND PROCESS FOR PRODUCING THE SAME | Japan Science and Technology Corporation (JP) | 2004-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092752-A1 | Optically active alkenylphosphinic acid esters and process for producing the same | APEH, ACOX1, PHOSPHO1 | SOAT2 369/4885SOAT1 310/4885FAAH 748/4885 |
| US-20080091040-A1 | Optically active alkenylphosphinic acid ester and process for producing the same | PHOSPHO1, APEH, ACP3 | SOAT2 247/4885SOAT1 171/4885FAAH 2163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.